| Financial Year |
March 31 2023 |
| Monetary Funds |
21,285,169,469.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
876,437,026.50 |
| Accounts Receivable |
3,412,467,845.00 |
| Advances to Suppliers |
1,108,180,551.09 |
| Other Receivables |
261,826,069.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,350,270,186.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,203,595.22 |
| Total Current Assets |
34,667,573,821.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
588,136,095.16 |
| Investment Properties |
-- |
| Fixed Assetes |
26,011,812,672.66 |
| Under-construction Projects |
1,078,996,783.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,335,712,119.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
91,986,824.77 |
| Deferred Income Tax Assets |
206,087,565.33 |
| Other Non-Current Assets |
193,323,183.42 |
| Sub-Total of Non-Current Assets |
30,543,555,922.13 |
| Total Assets |
65,211,129,743.73 |
| Short-Term Loans |
7,580,166,190.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
743,659,916.71 |
| Accounts Payable |
2,576,176,975.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
589,495,415.36 |
| Taxes Payable |
236,278,727.17 |
| Interest Payable |
-- |
| Dividend Payable |
6,107,297.49 |
| Other payables |
463,740,356.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,105,211.40 |
| Other Current Liabilities |
687,577,180.43 |
| Sub-Total of Current Liabilities |
13,460,783,801.00 |
| Long-term Loans |
320,348,486.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,056,700.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
945,381,665.51 |
| Total Liabilities |
14,406,165,466.51 |
| Paid-In Capital(Or Share Stock) |
11,708,552,848.00 |
| Capital Surplus |
15,909,903,918.52 |
| Surplus Reserve |
1,805,517,018.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
16,370,290,441.46 |
| Minority Stockholder's Interest |
5,033,544,408.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
45,771,419,868.35 |
| Owner's Equity（Stockholder's Equity） |
50,804,964,277.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
65,211,129,743.73 |
